Presight Capital

AbCellera is a biotechnology company that specializes in AI-powered drug discovery, focusing on the development of therapeutic antibodies.

Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.

Qonto is a business banking platform that offers a range of financial services tailored for SMEs, freelancers, and associations, including business accounts, payment cards, invoicing, and expense management.

Razor Group Interactive is a digital marketing agency specializing in website design, development, and inbound marketing strategies tailored for small businesses.

AtaiBeckley is a biotechnology company developing new mental health treatments to transform patient outcomes. Our research is focused on developing rapid-acting, robust and durable mental health treatments for large-scale patient impact.

Alto Neuroscience is a company focused on precision psychiatry and developing personalized psychiatric treatments, leveraging the biology of individuals' brains to create effective medicines.

Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality and deliver safe and effective cancer therapies to all.

Blackrock Neurotech is a pioneering company in neurotechnology, developing brain-computer interface (BCI) solutions that empower individuals with paralysis and other neurological disorders to interact with the world through thought.

Bullish is an institutionally focused global digital asset platform that provides market infrastructure and information services. The company aims to make trading with digital assets more rewarding and secure, prioritizing compliance and safeguarding customer assets through robust security measures.

Plasma is a high-performance layer 1 blockchain purpose-built for stablecoins, enabling near instant, fee-free payments with institutional-grade security.

Veteran VC and mountain guide-led firm focused on Colorado and the Mid-Atlantic, offering hands-on pre-investment partnership and local sourcing expertise while prioritizing realized exits over paper markups.

Stealthy investor across frontier sectors (space, biotech, AI) making sub-$500K average checks into technically complex startups with exceptional defensibility and operational guidance from GP Rob Ness's 2% Rule.

Pre-seed lead investor for deeply technical AI, biotech, climatetech and infrastructure startups, offering female operator-led go-to-market expertise and structured fellowships to source technical-founder deal flow. Divergent Capital is run by two female operator-investors who combine deep-tech investing experience with hands-on go-to-market expertise, and they cultivate deal flow through structured fellowships targeting students and emerging investors in their technical-founder network.

Early institutional backer that sources tech from academia and government labs, partnering with scientist- and engineer-led teams to deeply interrogate science, dual-use/defense opportunities, and amplify through an in-house media platform. Explicitly aims to "turn science fiction into science fact" by backing companies at the intersection of the new and the not-yet-imagined, built around scientists, engineers, and polymaths rather than traditional finance backgrounds who can deeply interrogate emerging science and complex tech. The firm systematically mines academia and government labs for "technological gems" and has become one of the earliest institutional backers of dual-use and defense technology.